Climb Bio (CLYM) Current Leases (2022 - 2026)
Climb Bio (CLYM) posted Current Leases of $263000.0 for Q1 2026, up 2.73% on a QoQ basis from $256000.0 in Q4 2025, and up 69.68% year-over-year from $155000.0 in Q1 2025.
Climb Bio (CLYM) Current Leases (2022 - 2026) Analysis & Trends
Climb Bio's Current Leases history runs 5 years deep, the most recent figure standing at $263000.0 for Q1 2026.
- Quarterly Current Leases rose 69.68% year-over-year to $263000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $263000.0 (up 69.68% YoY) and the FY2025 annual result came in at $256000.0, up 63.06% from the prior year.
- Current Leases was $263000.0 for Q1 2026 at Climb Bio, up from $256000.0 in the prior quarter.
- Across five years, Current Leases topped out at $485000.0 in Q2 2023 and bottomed at $58000.0 in Q3 2024.
- A 5-year average of $288117.6 and a median of $263000.0 in 2026 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases plunged 85.54% — and 2025, when it soared 293.1%.
- Climb Bio's Current Leases stood at $300000.0 in 2022, then grew by 11.33% to $334000.0 in 2023, then slumped by 52.99% to $157000.0 in 2024, then soared by 63.06% to $256000.0 in 2025, then advanced by 2.73% to $263000.0 in 2026.
- Business Quant data shows CLYM's Current Leases at $263000.0 in Q1 2026, $256000.0 in Q4 2025, and $228000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | 263,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 263,000.00 |
| Dec 31, 2025 | 256,000.00 |
| Sep 30, 2025 | 228,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Mar 31, 2025 | 155,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Sep 30, 2024 | 58,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 225,000.00 |
| Dec 31, 2023 | 334,000.00 |
| Sep 30, 2023 | 401,000.00 |
| Jun 30, 2023 | 485,000.00 |
| Mar 31, 2023 | 464,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 352,000.00 |
| Jun 30, 2022 | 439,000.00 |
| Mar 31, 2022 | 459,000.00 |